Direxion Daily LLY Bull 2X Shares $ELIL Shares Sold by Optiver Holding B.V.

Optiver Holding B.V. reduced its position in Direxion Daily LLY Bull 2X Shares (NASDAQ:ELIL) by 78.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,016 shares of the company’s stock after selling 50,405 shares during the quarter. Optiver Holding B.V.’s holdings in Direxion Daily LLY Bull 2X Shares were worth $271,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in ELIL. IMC Chicago LLC purchased a new position in Direxion Daily LLY Bull 2X Shares in the 1st quarter valued at $250,000. Susquehanna International Group LLP grew its holdings in shares of Direxion Daily LLY Bull 2X Shares by 148.0% during the third quarter. Susquehanna International Group LLP now owns 38,520 shares of the company’s stock worth $641,000 after buying an additional 22,987 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Direxion Daily LLY Bull 2X Shares in the third quarter valued at about $934,000. Finally, Goldman Sachs Group Inc. acquired a new stake in shares of Direxion Daily LLY Bull 2X Shares in the first quarter valued at about $585,000.

Direxion Daily LLY Bull 2X Shares Stock Performance

ELIL stock opened at $28.09 on Monday. Direxion Daily LLY Bull 2X Shares has a 12 month low of $11.50 and a 12 month high of $34.28. The firm has a 50-day moving average of $28.89 and a two-hundred day moving average of $24.82.

Direxion Daily LLY Bull 2X Shares Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 23rd were given a $0.1279 dividend. The ex-dividend date was Tuesday, June 23rd. This represents a $0.51 dividend on an annualized basis and a dividend yield of 1.8%.

About Direxion Daily LLY Bull 2X Shares

Direxion Shares ETF Trust – Direxion Daily LLY Bull 2X Shares is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund uses derivatives such as swaps and options to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization.